163 related articles for article (PubMed ID: 16586119)
1. Positive correlations between cerebral choline and renal dysfunction in chronic renal failure.
Sasaki O; Hattori N; Nakahama H; Inoue N; Nakamura S; Inenaga T; Kohno S; Sawada T; Kawano Y
Neuroradiology; 2006 May; 48(5):300-6. PubMed ID: 16586119
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of in vivo cerebral metabolism on proton magnetic resonance spectroscopy in patients with impaired glucose tolerance and type 2 diabetes mellitus.
Sahin I; Alkan A; Keskin L; Cikim A; Karakas HM; Firat AK; Sigirci A
J Diabetes Complications; 2008; 22(4):254-60. PubMed ID: 18413166
[TBL] [Abstract][Full Text] [Related]
3. Cerebral metabolite patterns in dialysis patients: evaluation with H-1 MR spectroscopy.
Geissler A; Fründ R; Kohler S; Eichhorn HM; Krämer BK; Feuerbach S
Radiology; 1995 Mar; 194(3):693-7. PubMed ID: 7862964
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of early cerebral metabolic, perfusion and microstructural changes in HCV-positive patients: a pilot study.
Bladowska J; Zimny A; Knysz B; Małyszczak K; Kołtowska A; Szewczyk P; Gąsiorowski J; Furdal M; Sąsiadek MJ
J Hepatol; 2013 Oct; 59(4):651-7. PubMed ID: 23680314
[TBL] [Abstract][Full Text] [Related]
5. Cerebral diffusion tensor imaging and in vivo proton magnetic resonance spectroscopy in patients with fulminant hepatic failure.
Saksena S; Rai V; Saraswat VA; Rathore RS; Purwar A; Kumar M; Thomas MA; Gupta RK
J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 2):e111-9. PubMed ID: 17924951
[TBL] [Abstract][Full Text] [Related]
6. Quantitative short echo time proton magnetic resonance spectroscopic imaging study of malformations of cortical development causing epilepsy.
Woermann FG; McLean MA; Bartlett PA; Barker GJ; Duncan JS
Brain; 2001 Feb; 124(Pt 2):427-36. PubMed ID: 11157569
[TBL] [Abstract][Full Text] [Related]
7. Proton MRS in acute traumatic brain injury: role for glutamate/glutamine and choline for outcome prediction.
Shutter L; Tong KA; Holshouser BA
J Neurotrauma; 2004 Dec; 21(12):1693-705. PubMed ID: 15684761
[TBL] [Abstract][Full Text] [Related]
8. A proton magnetic resonance spectroscopy study of the striatum and cerebral cortex in Parkinson's disease.
Taylor-Robinson SD; Turjanski N; Bhattacharya S; Seery JP; Sargentoni J; Brooks DJ; Bryant DJ; Cox IJ
Metab Brain Dis; 1999 Mar; 14(1):45-55. PubMed ID: 10348313
[TBL] [Abstract][Full Text] [Related]
9. Glutamatergic and Neuronal Dysfunction in Gray and White Matter: A Spectroscopic Imaging Study in a Large Schizophrenia Sample.
Bustillo JR; Jones T; Chen H; Lemke N; Abbott C; Qualls C; Stromberg S; Canive J; Gasparovic C
Schizophr Bull; 2017 May; 43(3):611-619. PubMed ID: 27550776
[TBL] [Abstract][Full Text] [Related]
10. Neurochemical correlates of cognitive dysfunction in patients with leukoaraiosis: a proton magnetic resonance spectroscopy study.
Wang S; Yuan J; Guo X; Peng P; Gu H; Niu S; Fregni F; Chen AC; Hu W
Neurol Res; 2012 Dec; 34(10):989-97. PubMed ID: 23146302
[TBL] [Abstract][Full Text] [Related]
11. In vivo 1H magnetic resonance spectroscopy-derived metabolite variations between acute-on-chronic liver failure and acute liver failure.
Verma A; Saraswat VA; Radha Krishna Y; Nath K; Thomas MA; Gupta RK
Liver Int; 2008 Sep; 28(8):1095-103. PubMed ID: 18266634
[TBL] [Abstract][Full Text] [Related]
12. Proton magnetic resonance spectroscopy in the distinction of high-grade cerebral gliomas from single metastatic brain tumors.
Server A; Josefsen R; Kulle B; Maehlen J; Schellhorn T; Gadmar Ø; Kumar T; Haakonsen M; Langberg CW; Nakstad PH
Acta Radiol; 2010 Apr; 51(3):316-25. PubMed ID: 20092374
[TBL] [Abstract][Full Text] [Related]
13. Quantitative proton MRS of Pelizaeus-Merzbacher disease: evidence of dys- and hypomyelination.
Hanefeld FA; Brockmann K; Pouwels PJ; Wilken B; Frahm J; Dechent P
Neurology; 2005 Sep; 65(5):701-6. PubMed ID: 16157902
[TBL] [Abstract][Full Text] [Related]
14. A multicenter in vivo proton-MRS study of HIV-associated dementia and its relationship to age.
Chang L; Lee PL; Yiannoutsos CT; Ernst T; Marra CM; Richards T; Kolson D; Schifitto G; Jarvik JG; Miller EN; Lenkinski R; Gonzalez G; Navia BA;
Neuroimage; 2004 Dec; 23(4):1336-47. PubMed ID: 15589098
[TBL] [Abstract][Full Text] [Related]
15. Dialysis and transplantation affect cerebral abnormalities of end-stage renal disease.
Michaelis T; Videen JS; Linsey MS; Ross BD
J Magn Reson Imaging; 1996; 6(2):341-7. PubMed ID: 9132100
[TBL] [Abstract][Full Text] [Related]
16. Metabolite concentrations in supraventricular white matter from teenage to early old age: A short echo time 1H magnetic resonance spectroscopy (MRS) study.
Raininko R; Mattsson P
Acta Radiol; 2010 Apr; 51(3):309-15. PubMed ID: 20170295
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of metabolic changes within the normal appearing gray and white matters in neurologically asymptomatic HIV-1-positive and HCV-positive patients: magnetic resonance spectroscopy and immunologic correlation.
Bladowska J; Zimny A; Kołtowska A; Szewczyk P; Knysz B; Gąsiorowski J; Furdal M; Sąsiadek MJ
Eur J Radiol; 2013 Apr; 82(4):686-92. PubMed ID: 23246331
[TBL] [Abstract][Full Text] [Related]
18. Metabolic Alterations Within the Primary Visual Cortex in Early Open-angle Glaucoma Patients: A Proton Magnetic Resonance Spectroscopy Study.
Guo L; Wang R; Tang Z; Sun X; Wu L; Wang J; Zhong Y; Xiao Z; Zhang Z
J Glaucoma; 2018 Dec; 27(12):1046-1051. PubMed ID: 30256276
[TBL] [Abstract][Full Text] [Related]
19. Single voxel proton magnetic resonance spectroscopy in post-stroke depression.
Glodzik-Sobanska L; Slowik A; McHugh P; Sobiecka B; Kozub J; Rich KE; Urbanik A; Szczudlik A
Psychiatry Res; 2006 Dec; 148(2-3):111-20. PubMed ID: 17088051
[TBL] [Abstract][Full Text] [Related]
20. [Proton magnetic resonance spectroscopy and diffusion tensor imaging study of first-episode patients with positive symptoms of schizophrenia].
Jia YB; Wang Y; Ling XY; Zhong SM; Huang L
Nan Fang Yi Ke Da Xue Xue Bao; 2012 Mar; 32(3):374-8. PubMed ID: 22445987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
